Alcon AG | ALC - Umsatzkosten





Umsatzkosten Veränderung Datum
AstraZeneca USD 2.52B 2.73B 2026-06
Bayer EUR 5.23B 731M 2026-03
Essilor EUR 5.55B 505M 2026-06
Fresenius EUR 4.45B 262M 2025-12
Fresenius Medical Care EUR 3.43B 248M 2026-03
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.08B 214.82M 2026-03
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.07B 219M 2026-03
Novartis USD 3.71B 251M 2026-06
Philips EUR 2.21B 70M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.67B 621M 2026-03
Smith & Nephew USD 870M 17M 2025-12
Sonova Holding CHF 539.4M 11.5M 2025-12
UCB EUR 1.07B 146M 2025-12